The Challenges of Rare Neurological Disease Drug Development
Citeline Podcasts - A podcast by Citeline
Categories:
In this episode, In Vivo speaks to Bruce Leuchter, CEO of Neurvati Neurosciences, about ways clinical drug development in rare neurologic diseases is being held back and what can be done to make the process more efficient and successful.
